Count Me In
If you had a chance to advance discoveries with leiomyosarcoma research, would you do it?
COUNT ME IN!
GET STARTED HERE
In partnership with Broad Institute’s COUNT ME IN project, LMSDR will be helping LMS patients donate their rare tumor tissue, blood, saliva and their LMS histories for researchers to study for free of charge. Your identifying information will be anonymous. However, USA patients WILL directly get the information about their own samples! READ MORE HERE
Watch our webinar for details
Update Message from: the new Coordinator: Benjamin Zola:
The LMS Project will perform Whole Exome Sequencing (WES) on tumor samples and matched germline samples. After performing this sequencing, we will aggregate all of the data we collect (including sequencing data, data from participant medical records, and patient-reported data from survey responses), remove any identifying information, and release it onto publicly available platforms so that researchers can use it to perform their own analyses.
In addition, as part of the project, participants will be able to decide if they’d like to provide an additional saliva sample to learn more about their/their child’s germline DNA and speak with a genetic counselor to understand these results. This additional germline sequencing will be performed directly through Invitae, who will conduct a multi-cancer panel test that analyzes 84 genes associated with hereditary cancers across major organ systems, including sarcomas.
